The RNA Leaders series brings together the scientific, clinical, and commercial communities driving the development of RNA medicines—including RNAi, antisense, non-linear RNAs, RNA editing and targeting, as well as mRNA therapy and vaccine manufacturing. In 2025, we’re excited to host the 4th European edition in March and the 4th USA edition in September, each expecting over 400 attendees. These events will welcome biotech leaders, discovery innovators, delivery specialists, manufacturers, big pharma, and investors to the premier senior-level RNA Leaders forum.
We’re also proud to announce the launch of our first RNA Leaders APAC meeting in October(15-16), designed to strengthen connections and collaboration in RNA therapeutics across the Asia-Pacific and Western regions.
We use cookies to personalise content and to analyse our traffic.
You consent to our cookies if you continue to use our website. Read more details in our
cookies policy.